LncRNA HITT inhibits autophagy by attenuating ATG12-ATG5-ATG16L1 complex formation

Hao Liu1, Xingwen Wang2, Bolun Li2

  • 1School of Life Science and Technology, Harbin Institute of Technology, Harbin, Heilongjiang Province, 150001, China; Key Laboratory of Science and Engineering for the Multi-modal Prevention and Control of Major Chronic Diseases, Ministry of Industry and Information Technology, HIT Zhengzhou Research Institute, Zhengzhou, 450000, China.

Cancer Letters
|February 28, 2025
PubMed

Insights

This study identifies HITT, a long non-coding RNA, as a novel regulator of autophagy. HITT inhibits autophagy, sensitizing cancer cells to death by blocking protective mechanisms.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Biology

Background:

  • Dysregulated autophagy is linked to cancer pathogenesis.
  • The role of long non-coding RNAs (lncRNAs) in autophagy is not well understood.

Purpose of the Study:

  • To investigate the role of the lncRNA HITT in autophagy.
  • To explore HITT's potential as a therapeutic target in cancer.

Main Methods:

  • Bioinformatic analysis to identify lncRNAs associated with autophagy.
  • Experimental validation of HITT's function in autophagy regulation.
  • In vitro and in vivo studies using PI-103 and nude mice models.

Main Results:

  • HITT expression increases with autophagic stimuli (e.g., PI-103).
  • HITT inhibits autophagy by preventing the formation of the ATG12-ATG5-ATG16L1 complex.
  • HITT sensitizes cancer cells to PI-103-induced death by attenuating protective autophagy.

Conclusions:

  • HITT is a novel RNA regulator of autophagy.
  • HITT can sensitize colon cancer cells to cell death by inhibiting protective autophagy.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K